risks of glp-1 drugs Nutritional Side Effects Drugs: Deficiencies, Muscle Loss, and What to Monitor GLP-1 Drugs Use, Risks, and
Description
The LEADER CVOT trial found a higher incidence of DR-associated events in a group treated with liraglutide compared with placebo
GIP, short for glucose-dependent insulinotropic polypeptide, is another hormone your body makes after you eat
Carrasco Barria, and M
Cardiovasc Res 118(18):34343450 Dhore-Patil A, Thannoun T, Samson R, Le Jemtel TH (2021) Diabetes mellitus and heart failure with preserved ejection fraction: role of obesity
doi: 10.1677/joe.0.1380159 [DOI] [PubMed] [Google Scholar] 57
Ozempic and Mounjaro Aren't the Same
